DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, announced that researchers from NYU Langone Health, in ...
As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...
While the U.S. election dominated global headlines, there has been lots of other news you may have missed, including Microsoft researchers who detected lung cancer risks through web search logs, and ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...
BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...
Early findings from the FANSS study, presented at ESMO Asia 2025, point to a potential shift in how clinicians identify lung ...
Talk about a breath of fresh air. Researchers have developed a groundbreaking device that may one day make detecting lung cancer as easy as exhaling. “We built a screening tool that could allow ...
Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.
A New York City woman is using her lung cancer survival story to push for early detection, especially among nonsmokers and those in underserved communities. Colette Smith of the Bronx wrote a message ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback